MARK ANTHONY ISON: Open Payments
NPI 1881152783 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$152 in 4 payments from 4 companies in 2025. Trend: 2023 $601 · 2024 $320 · 2025 $152
Food & beverage: $152
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $83 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Tris Pharma Inc | 1 | $19 |
Products named: Ozempic, HETLIOZ, TRINTELLIX, Dyanavel XR.
Industry payments across MD — which companies pay providers there.
